Yaron Naos serves as Executive at Protalix BioTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Yaron Naos has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 3, 2025 involved receiving (via award) 25,000 shares valued at $0.
Yaron Naos currently holds 225,817 shares of Protalix BioTherapeutics, Inc. (PLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yaron Naos has been a net neutral trader of PLX stock. They have purchased $0 and sold $0 worth of shares.
Yaron Naos's most recent insider trade was on Sep 3, 2025, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |